DIFFICULT TO TREAT ASTHMA

This book provides a practical, stepwise, evidence-based approach to the effective management of patients with difficult-to-treat asthma. The impact of asthma on morbidity and healthcare utilization increases exponentially with severity. Severe refractory asthma account for less than 5% of all asthma its prevalence however is often overestimated as there as several other confounding factors make asthma difficult to treat, many novel (albeit expensive) therapies are now available and providers caring for patients with severe asthma are charged with selecting the best evidence treatment. This call for complex and nuanced decision -making whether people with asthma gain and maintain control over their condition depends not only on the availability of effective drugs but also on multiple patient and healthcare provider behaviors, now more than ever it has become increasingly important to differentiate ?difficult? from sever refractory asthma to allow identification of patients most likely to benefit from these therapies.